Pharmafile Logo
Pharmafocus logo
Advanced Search

genome

Showing 8 posts of 8 posts found.

British researchers sequences 100,000 whole genomes

December 6, 2018
Research and Development Matt Hancock, digital, genome, personalised medicnie

British researchers have sequenced 100,000 whole genomes as part of an effort to improve understanding of rare diseases and move …

News
astrazeneca_sign_sky

AstraZeneca to sequence genomes to develop new drugs

April 22, 2016
Medical Communications, Sales and Marketing AstraZeneca, Finland, Wellcome Trust, collaboration, genome, genomics, human longevity, institute for molecular medicine, sanger institute

AstraZeneca (LSE: AZN) has announced an integrated genomics initiative that aims to transform the drug discovery and development across is …

News

Genome-driven lung cancer trial launches

June 18, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer

Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …

News
dna image

UK to launch DNA database

November 8, 2013
Sales and Marketing DNA, UK, crispr, genome

Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …

News
Wellcome Trust Sanger Institute

Study boost for personalised cancer treatments

July 23, 2010
Research and Development Cancer, genome, genomics, personalised medicine

A five-year study by scientists in the UK and US of the way genomes and cancer medicines interact has yielded …

News

First artificial life created

May 24, 2010
Research and Development Cell biology, Venter, cell, genome

Scientists in the US have succeeded in developing the first living cell to be controlled entirely by synthetic DNA. The …

News

Huge drug discovery database launched

January 26, 2010
Research and Development ChEMBLdb, Wellcome, genome, genomics

A huge online database of information on the properties and activities of drugs and drug-like small molecules and their targets …

News
Boehringer building at night

Boehringer targets ‘genome guardian’ protein for cancer collaboration

January 19, 2010
Research and Development Boehringer, Cancer, Priaxon, genome

Boehringer Ingelheim has signed a worldwide deal with Munich-based pharma firm Priaxon to find novel treatments for cancer. The firms …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025